substance misuse

No Boundaries : Tayside Domestic Abuse and Substance Misuse Project : Final Research Report

This report presents the results of a secondary analysis of data collected for the Tayside Domestic Abuse and Substance Misuse Project by a different research team. The secondary analysis was conducted by Dolev & Associates, with funding from the Scottish Government Multiple and Complex Needs Initiative. An attempt was made to identify depositional and organisational factors that shape the experiences of women who are affected by domestic abuse and their own substance misuse at each stage of their service use.

Effective interventions unit: integrated care pathways guide 1 - definitions and concepts

First in a series of guides on developing and implementing Integrated Care Pathways (ICPs). While ICPs have been developed within health settings, there is a growing interest in their development across a range of treatment and social care settings to ensure that a co-ordinated, quality service is provided over the full continuum of care. Care pathways are designed to minimise delays, make best use of resources, and maximise quality of care.

This guide examines when and how integrated care pathways can be used to provide better care for people with drug problems.

Parental substance misuse and the effects on children

This guidance has been developed for practitioners in Newcastle working with children and families and/or adults who have care of children where substance misuse is a factor, which affects their lives. It has been produced in response to the increasing problem of substance misuse and particularly the rising number of children who are referred into the child protection arena due to parental substance misuse.

Effective interventions unit: integrated care pathways guide 2 - developing integrated pathways

This is the second in a series of guides on developing and implementing Integrated Care Pathways (ICPs). This guide identifies the steps involved in developing an ICP and examines each process in more detail.

It is aimed at anyone involved in commissioning, planning, developing, delivering and evaluating services for drug users.

Tackling drugs: changing lives

Cross-government website for drug professionals and anyone interested in the national drug strategy.

In December 2002, the Government launched the Updated Drug Strategy 2002. This built upon, and adapted the Government's Drug Strategy Tackling Drugs to Build a Better Britain, launched in 1998. Aiming to reduce the harm that drugs cause to society - communities, individuals and their families - the Drug Strategy has four main elements: young people, reducing supply, communities, treatment.

National and regional estimates of the prevalence of opiate use and/or crack cocaine use 2006/07: a summary of key findings

This report summarises the results of the third and final sweep of a study to estimate the prevalence of ‘problem drug use’ (defined as use of opiates and/or crack cocaine) nationally (England only), regionally, and locally. An overview of national and Government Office Region estimates are presented in this report, as are comparisons with the estimates produced by the second (2005/06) sweep of the study.

The Tayside Domestic Abuse and Substance Misuse Project : Final Research Report : Summary of Findings

This resource is a summary of a research report into the Tayside Domestic Abuse and Substance Misuse Project. The findings presented in this report include a review of the literature on the links between domestic abuse and substance misuse, and secondary analysis of service user questionnaires, interviews with service users and interviews with domestic abuse and substance misuse service providers.

Drug misuse and dependence : UK guidelines on clinical management

This resource is intended for all clinicians, especially those providing pharmacological interventions for drug misusers as a component of drug misuse treatment. The report discusses the effectiveness of drug treatment, the impact of drug misuse on families and communities, psychosocial components of treatment, health considerations including preventing drug-related death and blood-borne infections and considered specific treatment situations and populations such as mental health, criminal justice, pregnancy, young people and prisons.